Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

CASTOR Trial: Daratumumab Combination Doubles Response Rates in Myeloma Patients

December 30, 2021

Antonio Palumbo, MD, discusses the "unprecedented" results of the CASTOR Trial, a plenary, late-breaking abstract at ASCO 2016.

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
October 2024

Advertisement intended for health care professionals

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals